We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-4.23%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$279B
AUM Growth
-$8.2B
Cap. Flow
+$8.77B
Cap. Flow %
3.14%
Top 10 Hldgs %
16.93%
Holding
3,614
New
79
Increased
2,461
Reduced
704
Closed
105

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$441M
2
AVGO icon
Broadcom
AVGO
+$328M
3
PFE icon
Pfizer
PFE
+$292M
4
TSLA icon
Tesla
TSLA
+$252M
5
IBM icon
IBM
IBM
+$209M

Sector Composition

Rank Sector Weight
1 Technology 19.91%
2 Financials 13.22%
3 Healthcare 13.19%
4 Consumer Discretionary 10.07%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMPX icon
3251
Compass Therapeutics
CMPX
$344M
$73K ﹤0.01%
+31,736
New +$87.9K
RVSB icon
3252
Riverview Bancorp
RVSB
$107M
$73K ﹤0.01%
11,437
XFOR icon
3253
X4 Pharmaceuticals
XFOR
$375M
$73K ﹤0.01%
+1,413
New +$48.8K
IVAC
3254
DELISTED
Intevac Inc
IVAC
$73K ﹤0.01%
15,485
AKUS
3255
DELISTED
Akouos Inc
AKUS
$73K ﹤0.01%
10,685
ZOM
3256
DELISTED
Zomedica Corp.
ZOM
$73K ﹤0.01%
343,967
IMMR icon
3257
Immersion
IMMR
$251M
$72K ﹤0.01%
13,101
KG
3258
Kestrel Group
KG
$69.4M
$71K ﹤0.01%
1,648
LNSR icon
3259
LENSAR
LNSR
$61.5M
$70K ﹤0.01%
+12,582
New +$76.3K
OWLT icon
3260
Owlet
OWLT
$149M
$70K ﹤0.01%
4,651
ZVRA icon
3261
Zevra Therapeutics
ZVRA
$562M
$70K ﹤0.01%
11,139
AIOT
3262
PowerFleet Inc
AIOT
$526M
$70K ﹤0.01%
22,541
CLVS
3263
DELISTED
Clovis Oncology, Inc.
CLVS
$70K ﹤0.01%
58,000
-515,476
-90% -$804K
DTIL icon
3264
Precision BioSciences
DTIL
$180M
$67K ﹤0.01%
1,709
-5,499
-76% -$261K
SVRA icon
3265
Savara
SVRA
$1.12B
$67K ﹤0.01%
42,882
DRRX
3266
DELISTED
DURECT Corp
DRRX
$66K ﹤0.01%
11,344
GORO icon
3267
Goldgroup Mining Inc.
GORO
$157M
$66K ﹤0.01%
39,537
NEOV icon
3268
NeoVolta
NEOV
$116M
$66K ﹤0.01%
+12,964
New +$56.1K
PHUN icon
3269
Phunware
PHUN
$43.1M
$66K ﹤0.01%
1,110
+588
+113% +$42.1K
VTGN icon
3270
VistaGen Therapeutics
VTGN
$9.89M
$66K ﹤0.01%
14,265
-3,760
-21% -$37.3K
EVLO
3271
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$66K ﹤0.01%
1,567
-4,396
-74% -$201K
TOON icon
3272
Kartoon Studios
TOON
$35.2M
$64K ﹤0.01%
10,629
VSTM icon
3273
Verastem
VSTM
$510M
$64K ﹤0.01%
6,272
OSG
3274
DELISTED
Overseas Shipholding Group Inc.
OSG
$64K ﹤0.01%
21,455
-14,427
-40% -$39K
ANIX icon
3275
Anixa Biosciences
ANIX
$116M
$63K ﹤0.01%
12,785
-11,431
-47% -$46.3K

Similar funds

Charles Schwab's Q3 2022 Portfolio in Review

As of Q3 2022, Charles Schwab held 3,614 positions worth $279B, down 2.9% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab deployed $8.77B of net new capital in Q3 2022, opening 79 new positions and adding to 2,461 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $295M trimmed.

  • Charles Schwab's largest Q3 2022 buy was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
  • Charles Schwab added most to Verizon in Q3 2022, an estimated $441M increase.
  • Charles Schwab's biggest Q3 2022 reduction was iShares National Muni Bond ETF, cutting an estimated $295M.
  • Charles Schwab fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $91.4M.
  • Charles Schwab's ten largest holdings make up 17% of its $279B portfolio in Q3 2022.
  • Charles Schwab opened 79 new positions and closed 105 in Q3 2022.
  • Charles Schwab's portfolio value fell 2.9% quarter-over-quarter to $279B.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.